generic antihypertensives

 

Published July 2017  ·  Report No. GJH334K · Price US $875

 


In terms of the number of unique products, generic antihypertensives are the largest single generic therapeutic drug category with more than one hundred unique API and API combination products current marketed. However, there do exist unique dosages that are currently underserved and may represent an unmet need. These instances represent potential opportunities for generic drug participants. By developing visual management decision support tools such as the Generic Antihypertensives report, we assist managers and related stakeholders in discovering the difficult-to-identify growth opportunities in the highly competitive and rapidly evolving generic drug market.

 

 

Report Brochure (Download PDF)

 

Report Order Form (Download PDF)

 


Generic Antihypertensives – Content Highlights

• Provides analysis of generic drugs indicated for the treatment of hypertension
• Presents the competitive picture for generic antihypertensives.
• Evaluates the importance of ANDA filing strategies and indirect ANDA acquisition on participant growth prospects
• Analyzes the impact of patents, exclusivity and litigation on participant market sector prospects
• Assesses the market presence and product position of the top generic antihypertensive suppliers


Generic Antihypertensives – Summary of Contents

Generic Markets Overview

Major Market Segments for Generic Drugs

FDA Approved Generic Drugs by Therapeutic Class

Therapeutic Classes for Generic Cardiology Drugs

Generic Hypertensives – Approved Product Charts

Amlodipine Besylate

Atenolol

Benazepril

Clonidine

Diltiazem

Enalapril

Felodipine

Fosinopril

Guanfacine

Hydralazine

Hydrochlorothiazide

Irbesartan

Labetalol

Lisinopril

Losartan

Metoprolol

Milrinone

Nadolol

Nicardipine

Olmesartan

Quinapril

Ramipril

Telmisartan

Timolol

Trandolapril

Valsartan

Verapamil

Key Generic Drug Opportunity Factors

Saturation Index

API Opportunity Index

P(iv) Antihypertensives Drug Index

Orange Book Antihypertensives Drug Patent Staircase Analysis

Generic Antihypertensive Drugs – Company Activity Maps

Detailed Charts for top 25 Antihypertensive Generic Participants